Orally-active elastase inhibitors

Details Orally-active elastase inhibitors Orally-active elastase inhibitors

1994-10-13

1995-12-26

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 18, 530330, 530331, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

054788110

ABSTRACT:
This invention relates to novel morpholinourea and related derivatives of pentafluoroethyl peptides which are orally active elastase inhibitors. These compounds are useful in the treatment of various inflammatory diseases and emphysema.

REFERENCES:
patent: 4277395 (1981-07-01), Bey et al.
patent: 4518528 (1985-05-01), Rasnick
patent: 4623639 (1986-11-01), Hassall
patent: 4629724 (1986-12-01), Ryono et al.
patent: 4636489 (1987-01-01), Seemuller et al.
patent: 4643991 (1987-02-01), Digenis
patent: 4855303 (1989-08-01), Hoover
patent: 4873221 (1989-10-01), Trainor
patent: 4880780 (1989-11-01), Trainor et al.
patent: 4910190 (1990-03-01), Bergeson et al.
patent: 4935405 (1990-06-01), Hoover et al.
patent: 5055450 (1991-10-01), Edwards et al.
patent: 5114927 (1992-05-01), Schirlin
patent: 5162307 (1992-11-01), Digenis et al.
Biochemistry, Imperiali et al., Inhibition of Serene Protease by Peptidyl Flourumethyl Ketones, vol. 25, pp. 3760-3767 (1986).
Shah et al, "Orally Active .beta.-Lactam Inhibitors of Human Leukocyte Elastase-1". J. Med Chem, 35, pp. 3745-3754 (1992).
Snider, "Experimental Studies on Emphysema and Chronic Bronchial Injury", Eur. J. Respir Dis (1986) 69 (Suppl. 146) pp. 17-35.
Malech et al, "Current Concepts: Immunology Neutrophils in Human Diseases", New Engl. J. Med., 317, 687-694 (1987).
Fletcher et al, "A comparison of .alpha..sub.1- Proteinase Inhibitor Methoxysuccinyl-ala-ala-pro-val-chloromethylketone and Specific .beta.-Lactam Inhibitors in a accute Model of Human Polymorphonuclear Leukocyte Elastase-induced Lung Hemorrhage in the hamster", Am Rev Respir (1990); 141:672-677.
Hassall et al, "A new class of inhibitors of human leucocyte elastase", FEBS Lett., 183, 201-205 (1985).
Travis, J. et al., "Potential Problems in Designing Elastase Inhibitors for Therapy," Am Rev Respir Dis, Pulmonary Perspective, vol. 143 pp. 1412-1415 1991.
Petrillo, E. W., et al., Chapter 6. Antihypertensive Agents, Section II. Cardiovascular and Pulmonary Agents, Annual Reports in Medicinal Chemistry, 25, 1989, Academic Press, Inc., D. W. Robertson Editor.
Chemical Abstract vol. 111, No. 21, Nov. 20, 1989, Galzigna et al. Abst #190131z.
Chemical Abstract Vo. 111, No. 9, Aug. 28, 1989, Lafuma et al Abst. #70314q.
Peet et al., "Synthesis of Peptidyl Fluoromethyl Ketones and Peptidyl .alpha.-Keto Esters as Inhibitors of Porcine Pancreativ Elastase, Human Neutrophil Elastase, and Rat and Human Neutrophil Cathepsin G", J. Med. Chem. 33, pp. 394-407, (1990).
Angelastro, et al., "Inhibition of Human Neutrophil Elastase with Peptidyl Electrophilic Ketones. 2. Orally Active P.sub.G -Val-Pro-Val Pentafluoroethyl Ketones" J. Med. Chem. 37, pp. 4538-4553, (1994).
"Communications tothe Editor", J. Med. Chem. 33, pp. 11-13, (1990).
Angelastro et al., "Synthesis of a Peptidyl 2,2-Difluror-3-Aminopropionate", Biorganic and Medicinal Chemistry Letters, vol. 2, pp. 1235-1238, (1992).
Angelastro, et al., "Janus Compounds: Dual Inhibitors of Proteinases", Bioorganic and Medicinal Chemistry Letters, vol. 3, No. 4, pp. 525-530, (1993).
Mehdi, S., "Synthetic and Naturally Occurring Protease Inhibitors Containing an Electrophilic Carbonyl Group", Bioorganic Chemistry 21, pp. 249-259, (1993).
Angelastro, et al., "Efficient Preparation of Peptidyl Pentafluoroethyl Ketones", Tetrahedron Letters, vol. 33, No. 23, pp. 3265-3268, (1992).
Burkhart, et al., "A Novel Method for the Preparation of Peptidyl .alpha.-Keto Esters" Tetrahedron Letters, vol. 33, No. 23, pp. 3265-3268, (1992).
Angelastro, et al, "An Efficient Synthesis of Novel .alpha.-Diketone and .alpha.-Keto Ester Derivatives of N-Protected Amino Acids and Peptides" J. Org. Chem. 54, pp. 3913-3916, (1989).
Burkhart et al., "Inhibition of Human Neutrophil Elastase. 3. An Orally Active Enol Acetate Prodrug" J. Med. Chem. 38, (1995) p. 223.
Skiles et al., J. of Medicinal Chemistry, vol. 35, No. 4, pp. 641-662 (1992).
Repine et al., J. Med. Chem. 34, pp. 1935-1943, (1991).
Ueda et al., Biochem. J. 265, pp. 539-545, (1990).
Sham, H. L. et al., FEBS Letters, Vo. 1. 220, No. 2, pp. 299-301, (1987).
Powers, J. C., Eleventh American Peptide Syposium, Abstracts, The Salk Institute and U. of CA, San Diego (1989).
Mehdi, et al, Biochemical and Biophysical Research Communications, pp. 595-600, vol. 166, No. 2, 1990.
Doherty et al, Int. J. Immunopharmac. Vo. 12, No. 7, pp. 787-795, 1990.
Peet, et al., 1989 American Chemical Society, J. Med. Chem, 1990, 33, 394-407.
Travis et al, Structure, Functino and Control of Neutrophil Proteinases, Jun. 24, 1988, The American Journal of Medicine, vol. 84, pp. 37-42.
Rice et al., Science, vol. 249, pp. 178-181 (1990).
Nakajima et al., The Journal of Biological Chemistry, vol. 254, No. 10, pp. 4027-4032 (1979).
Reilly et al., Biochimica et Biophysica Acta, vol. 621, pp. 147-157 (1980).
McWherter et al., Biochemistry, vol. 28, No. 14, pp. 5708-5714 (1989).
Steinmeyer et al., Arneimittel-Forschung/Drug Research, vol. 41(1), o.1, pp. 77-80 (1991).
Powers et al., Chemical Abstracts 108: 33954r (1988).

Affiliated with

Also associated with

Rating

Orally-active elastase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally-active elastase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally-active elastase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1369247